New coaching tool aims to improve cancer decisions for dementia patients
NCT ID NCT06313853
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a communication program called COACH-Cog for older adults with both dementia and cancer. It includes a training video for doctors and a coaching session for patients and their care partners. The goal is to see if this helps everyone work together better when making cancer treatment decisions. About 300 people will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- communication coaching session and clinician training video
- What this could lead to
- If it works, this could improve how doctors, patients, and families talk about cancer treatment options for people with dementia.
- What could go wrong
- This is a small, early pilot study, so results may not apply widely. The intervention is behavioral, not a drug, so benefits may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Rochester Wilmot Cancer Institute
RECRUITINGRochester, New York, 14620, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could sitting up make radiation therapy more comfortable?
- Could your heart hold the key to Alzheimer's prevention?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can we predict dangerous side effects when combining radiation and immunotherapy?